These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 10721642

  • 1. Immune response in acute coronary syndromes.
    Jan V, Jalal S, Aslam K, Iqbal K, Tramboo N, Alai MS, Rather H, Lone N.
    Indian Heart J; 1999; 51(5):515-20. PubMed ID: 10721642
    [Abstract] [Full Text] [Related]

  • 2. Complement activation in acute coronary syndromes.
    Iltumur K, Karabulut A, Toprak G, Toprak N.
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [Abstract] [Full Text] [Related]

  • 3. Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events.
    Palikhe A, Sinisalo J, Seppänen M, Haario H, Meri S, Valtonen V, Nieminen MS, Lokki ML.
    Am J Cardiol; 2007 Apr 01; 99(7):890-5. PubMed ID: 17398178
    [Abstract] [Full Text] [Related]

  • 4. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G, Hedblad B, Janzon L, Lindgärde F.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 01; 14(3):392-7. PubMed ID: 17568238
    [Abstract] [Full Text] [Related]

  • 5. A pilot study of cardiac troponin I in patients with acute myocardial infarction and unstable angina.
    Selim NA, Hmouda HT.
    Saudi Med J; 2002 May 01; 23(5):526-8. PubMed ID: 12070573
    [Abstract] [Full Text] [Related]

  • 6. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.
    Circulation; 2003 Sep 30; 108(13):1560-6. PubMed ID: 12975259
    [Abstract] [Full Text] [Related]

  • 7. Improved in-hospital outcomes in acute coronary syndromes (unstable angina/non-ST segment elevation myocardial infarction) despite similar TIMI risk scores.
    Almeda FQ, Hendel RC, Nathan S, Meyer PM, Calvin JE, Klein LW.
    J Invasive Cardiol; 2003 Sep 30; 15(9):502-6. PubMed ID: 12947210
    [Abstract] [Full Text] [Related]

  • 8. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF, Theander E, Blom AM, Trouw LA.
    Scand J Immunol; 2009 Apr 30; 69(4):374-80. PubMed ID: 19284503
    [Abstract] [Full Text] [Related]

  • 9. Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy.
    Sampietro T, Bigazzi F, Rossi G, Dal Pino B, Puntoni MR, Sbrana F, Chella E, Bionda A.
    J Intern Med; 2005 Jun 30; 257(6):523-30. PubMed ID: 15910556
    [Abstract] [Full Text] [Related]

  • 10. [Immunological characteristics of patients with acute coronary syndrome (unstable angina and myocardial infarction)].
    Logacheva IV, Leshchinskiĭ LA, Zvorygin IA.
    Klin Med (Mosk); 1999 Jun 30; 77(4):23-5. PubMed ID: 10356912
    [Abstract] [Full Text] [Related]

  • 11. Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration.
    Tziakas DN, Chalikias GK, Parissis JT, Hatzinikolaou EI, Papadopoulos ED, Tripsiannis GA, Papadopoulou EG, Tentes IK, Karas SM, Chatseras DI.
    Int J Cardiol; 2004 Apr 30; 94(2-3):269-77. PubMed ID: 15093992
    [Abstract] [Full Text] [Related]

  • 12. Differences in inflammatory and thrombotic markers between unstable angina and acute myocardial infarction.
    Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Tsoufis C, Marinou K, Charakida M, Stefanadi E, Vavuranakis M, Latsios G, Stefanadis C.
    Int J Cardiol; 2007 Feb 07; 115(2):203-7. PubMed ID: 16787670
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of thrombolysis with alteplase (50 mg) plus tirofiban versus alteplase (100 mg) alone in acute myocardial infarction: preliminary findings.
    Sarullo FM, Pasquale PD, D'Alfonso G, Amerigo L, Cannizzaro S, Castello A.
    Ital Heart J; 2001 Aug 07; 2(8):605-11. PubMed ID: 11577835
    [Abstract] [Full Text] [Related]

  • 14. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, McCabe CH, Braunwald E, TIMI Study Group.
    Am Heart J; 2006 Oct 07; 152(4):756-61. PubMed ID: 16996854
    [Abstract] [Full Text] [Related]

  • 15. [Complement system proteins in the acute phase of myocardial infarction].
    Gukasian IA, Kovanov VV, Khil'kin AM, Shmelev IA.
    Vopr Med Khim; 1980 Oct 07; 26(3):362-5. PubMed ID: 7456367
    [Abstract] [Full Text] [Related]

  • 16. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
    French JK, Ramanathan K, Stewart JT, Gao W, Théroux P, White HD.
    Am Heart J; 2003 Mar 07; 145(3):508-14. PubMed ID: 12660675
    [Abstract] [Full Text] [Related]

  • 17. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM, Schicchi R, Schirò M, Americo L, Bonnì G, Faraone N, Di Pasquale P, Castello A, Mauri F.
    Ital Heart J Suppl; 2000 Jan 07; 1(1):81-7. PubMed ID: 10832123
    [Abstract] [Full Text] [Related]

  • 18. Cytokines in patients with ischaemic heart disease or myocardial infarction.
    Bossowska A, Kiersnowska-Rogowska B, Bossowski A, Galar B, Sowiński P.
    Kardiol Pol; 2003 Aug 07; 59(8):105-14. PubMed ID: 14560325
    [Abstract] [Full Text] [Related]

  • 19. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction.
    Okmen E, Cakmak M, Tartan Z, Cam N.
    Heart Vessels; 2003 Jul 07; 18(3):117-22. PubMed ID: 12955426
    [Abstract] [Full Text] [Related]

  • 20. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
    Peters RJ, Spickler W, Théroux P, White H, Gibson M, Molhoek PG, Anderson HV, Weitz JI, Hirsh J, Weaver WD.
    Am Heart J; 2001 Aug 07; 142(2):237-43. PubMed ID: 11479461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.